Publicaciones en las que colabora con Elisa Herráez Aguilar (19)

2023

  1. Relevance of the organic anion transporting polypeptide 1B3 (OATP1B3) in the personalized pharmacological treatment of hepatocellular carcinoma

    Biochemical Pharmacology, Vol. 214

  2. Role of organic cation transporter 3 (OCT3) in the response of hepatocellular carcinoma to tyrosine kinase inhibitors

    Biochemical Pharmacology, Vol. 217

2022

  1. Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers

    Cancers, Vol. 14, Núm. 14

2020

  1. Cellular mechanisms accounting for the refractoriness of colorectal carcinoma to pharmacological treatment

    Cancers, Vol. 12, Núm. 9, pp. 1-34

  2. Clinical relevance of the relationship between changes in gut microbiota and bile acid metabolism in patients with intrahepatic cholangiocarcinoma

    HEPATOBILIARY SURGERY AND NUTRITION

  3. Molecular bases of mechanisms accounting for drug resistance in gastric adenocarcinoma

    Cancers, Vol. 12, Núm. 8, pp. 1-29

  4. Plasma Membrane Transporters as Biomarkers and Molecular Targets in Cholangiocarcinoma

    Cells, Vol. 9, Núm. 2

  5. Sensitizing gastric adenocarcinoma to chemotherapy by pharmacological manipulation of drug transporters

    Biochemical Pharmacology, Vol. 171

2019

  1. Models for understanding resistance to chemotherapy in liver cancer

    Cancers, Vol. 11, Núm. 11

2018

  1. Chemoresistance and chemosensitization in cholangiocarcinoma

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 4, pp. 1444-1453

  2. Genetic heterogeneity of SLC22 family of transporters in drug disposition

    Journal of Personalized Medicine, Vol. 8, Núm. 2

  3. Molecular bases of the poor response of liver cancer to chemotherapy

    Clinics and Research in Hepatology and Gastroenterology

  4. Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib

    Oncotarget, Vol. 9, Núm. 47, pp. 28474-28485

2017

  1. Usefulness of the MRP2 promoter to overcome the chemoresistance of gastrointestinal and liver tumors by enhancing the expression of the drug transporter OATP1B1

    Oncotarget, Vol. 8, Núm. 21, pp. 34617-34629

2014

  1. Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development

    Molecular Cancer Research, Vol. 12, Núm. 1, pp. 91-100

  2. Role of macrophages in bile acid-induced inflammatory response of fetal lung during maternal cholestasis

    Journal of Molecular Medicine, Vol. 92, Núm. 4, pp. 359-372

2013

  1. Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib

    Hepatology, Vol. 58, Núm. 3, pp. 1065-1073

2009

  1. In vitro inhibition of OATP-mediated uptake of phalloidin using bile acid derivatives

    Toxicology and Applied Pharmacology, Vol. 239, Núm. 1, pp. 13-20

  2. Protective effect of bile acid derivatives in phalloidin-induced rat liver toxicity

    Toxicology and Applied Pharmacology, Vol. 239, Núm. 1, pp. 21-28